Adverse events associated with individual statin treatments for cardiovascular disease: an indirect comparison meta-analysis

Intensive statin therapy compared with moderate dosing for prevention of cardiovascular events: a meta-analysis of >40 000 patients

(2011) Edward J. Mills et al.   EUROPEAN HEART JOURNAL

Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis

(2010) Vasilios G Athyros et al.   LANCET

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

(2010) Naveed Sattar et al.   LANCET

Statin Adverse Effects

(2009) Beatrice A Golomb et al.   American Journal of Cardiovascular Drugs

Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial

(2009)   LANCET

Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis

(2009) Bengt C. Fellström et al.   NEW ENGLAND JOURNAL OF MEDICINE

Incorporating multiple interventions in meta-analysis: an evaluation of the mixed treatment comparison with the adjusted indirect comparison

(2009) Christopher O'Regan et al.   Trials

Atorvastatin prevents atrial fibrillation in patients with bradyarrhythmias and implantation of an atrial-based or dual-chamber pacemaker: A prospective randomized trial

(2008) Chia-Ti Tsai et al.   AMERICAN HEART JOURNAL

Comparison of Benefits and Risks of Rosuvastatin Versus Atorvastatin from a Meta-Analysis of Head-to-Head Randomized Controlled Trials

(2008) John Wlodarczyk et al.   AMERICAN JOURNAL OF CARDIOLOGY

Atorvastatin Therapy May Reduce the Incidence of Sudden Cardiac Death in Patients With Advanced Chronic Heart Failure

(2008) Bojan Vrtovec et al.   JOURNAL OF CARDIAC FAILURE

Primary Prevention of Cardiovascular Mortality and Events With Statin Treatments

(2008) Edward J. Mills et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis

(2008)   LANCET

Over-the-Counter Sales of Statins and Other Drugs for Asymptomatic Conditions

(2008) Mary E. Tinetti   NEW ENGLAND JOURNAL OF MEDICINE

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

(2008) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE

A 6 month randomized, double blind, placebo controlled, multi-center trial of high dose atorvastatin on myocardial perfusion abnormalities by positron emission tomography in coronary artery disease

(2007) Stefano Sdringola et al.   AMERICAN HEART JOURNAL

Effect of Early Use of Low-Dose Pravastatin on Major Adverse Cardiac Events in Patients With Acute Myocardial Infarction

(2007) Hiroshi Sato et al.   CIRCULATION JOURNAL

Long-term effects of pravastatin and fosinopril on peripheral endothelial function in albuminuric subjects

(2006) Folkert W. Asselbergs et al.   ATHEROSCLEROSIS